“…Indeed, the neuroinflammation induced by LPS has been related to ABBREVIATIONS: CT-L, chymotrypsin-like; DG, dentate gyrus; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GCDG, green cell in dentate gyrus; GFAP, glial fibrillary acidic protein; GFP, green fluorescent protein; Iba-1, ionized calcium-binding adapter molecule 1; NeuN, neuronal nuclei; P2Y 2 , P2Y purinoceptor 2; P2Y 2 R, P2Y purinoceptor 2 receptor; P2Y 2 R 2/2 , P2Y purinoceptor 2 receptor deficient; PG-L, postglutamyl-like; Ub G76V -GFP/UbGFP, ubiquitin G76V -green fluorescent protein; Up 4 U, diuridine tetraphosphate; UPS, ubiquitin-proteasome system; WT, wild type alterations in the expression of the 20S catalytic subunits b5 and b5i, as well as in the catalytic proteasomal activity (9)(10)(11). Additionally, the proteasome 20S complex subunit b4 and the 19S complex subunit Rpn9 have been, respectively, involved in the neuronal loss (12) and the production of proinflammatory mediators (13) caused by LPS-induced neuroinflammation. However, which molecular mechanisms underlying the proteasomal alterations are produced by the LPS-induced neuroinflammation, as well as which neural lineages are more susceptible to these changes, are still unresolved questions.…”